FDA approves Freenome's blood test for colorectal cancer screening
- Posted on July 27, 2026
- By Bing News
- 0 Views
- 1 min read
In brief
Generating AI summary…
FDA approves Freenome's blood test for colorectal cancer screening
July 27 (Reuters) - The U.S. FDA has approved Freenome's blood-based colorectal cancer screening test for older adults, paving the way for partner Abbott to launch it in the U.S. this fall, the companies said on Monday. Shares of Freenome rose about 10% in premarket trading. • The U.S. Food and Drug Administration's approval for average-risk adults aged 45 and older gives Freenome its first
